Trial Profile
Japan registry to use of Promus element in acute coronary syndrome patients
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 10 Dec 2016
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Acute coronary syndromes; Angina pectoris; Cardiovascular disorders; Coronary artery disease; Coronary artery restenosis; Myocardial infarction
- Focus Therapeutic Use
- Acronyms J-POSEIDON
- 20 Jun 2013 New trial record